Skip to main content

Table 4 Comparison between levels of MMP-1 as regard to diagnosis of the CLD group

From: Matrix metalloproteinase-1 as a non-invasive biomarker to assess liver fibrosis in children with chronic liver disease

Diagnosis MMP-1 ng/ml Test P value
Mean ± SD Range
Autoimmune hepatitis 15.1 ± 1.9 11.5‑21.5 F = 2.6 0.071
Cholestasis Biliary atresia 12.7 ± 3.4 6‑18.5
Familial intrahepatic cholestasis 13.3 ± 2.3 8‑15.5
Viral hepatitis HBV 14.7 ± 2.6 12.5‑17
HCV 15.9 ± 1.6 15.5‑19
Congenital hepatic fibrosis 14.5 ± 2.8 9.1‑16
Metabolic liver diseases Glycogen storage disease 16.6 ± 3.9 12‑20.5
Wilson disease 13.4 ± 3.9 7.1‑19
Tyrosinemia 14.3 ± 1.6 5‑19
Neiman pick 12.5 ± 1.5 8.5‑15
Chronic hepatitis for differential diagnosis 16.1 ± 5.5 6‑19.5
  1. HBV hepatitis B virus, HCV hepatitis C virus, F one-way ANOVA, MMP matrix metalloproteinase